Results 131 to 140 of about 6,404 (193)

Risk of autoimmune disease flares after recombinant zoster vaccine: A vaccine safety analysis based on the Vaccine Adverse Event Reporting System database. [PDF]

Hum Vaccin Immunother
Liu G, Zhang X, Wang Y, Wang Y, He P, Yu Q.   +5 more
europepmc   +1 more source

Recombinant Zoster Vaccine Use to Prevent Recurrent Shingles in an Adolescent Renal Transplant Recipient. [PDF]

Cureus
Nikfarjam N, Grimm P.
europepmc   +1 more source

Protective Effects of Recombinant Zoster Vaccine and Antiviral Therapy Against Cardiovascular Disease Following Herpes Zoster Infection. [PDF]

J Infect Dis
Xu X, Ray I, Tang E, Arnold BF, Acharya NR.   +4 more
europepmc   +1 more source

Post-Marketing Surveillance of Adverse Events Following Recombinant Zoster Vaccine - China, 2020-2023. [PDF]

China CDC Wkly
Li Y, Li K, Ren M, Li Y, Zhang L, Fan C, Zhang Z, Cao L, Yu W, Yin Z.   +9 more
europepmc   +1 more source

Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years. [PDF]

Clin Infect Dis
Rayens E, Sy LS, Qian L, Wu J, Ackerson BK, Luo Y, Zheng C, Cheng Y, Vega Daily LI, Song J, Takhar HS, Ku JH, Cohen RA, Yun H, Oraichi D, Seifert H, Tseng HF.   +16 more
europepmc   +1 more source

Unilateral Laterothoracic Exanthem in an Adult Following Recombinant Zoster Vaccination

Dermatology Practical & Conceptual
Liu, Xinjin, Song, Deyu, Jiang, Xian
openaire   +3 more sources

Cost Effectiveness of Recombinant Zoster Vaccine and Live-Attenuated Vaccine Against Herpes Zoster for Adults Aged 50 and Over in China. [PDF]

Pharmacoecon Open
Liu L, Zhang Q, Shu Y, Wang L, Shuai Z, Chu M, Zhang Z, Zhang R.   +7 more
europepmc   +1 more source

Effectiveness and safety of the recombinant zoster vaccine in adult patients with systemic lupus erythematosus: a claims-based retrospective cohort study in the USA. [PDF]

RMD Open
Mayer SE, Kluberg SA, Spence O, Oraichi D, Seifert H, Ali O, Yun H, Simon AL, Ko JS, Hugh C, Her M, Shattuck K, Jamal-Allial A, Djibo DA, Daniels K, Ma Q, McMahill-Walraven CN, Ogilvie RP, Palmsten K, Selvan M, Ziyadeh N, Ogdie A, George MD.   +22 more
europepmc   +1 more source

Evaluating the Immunogenicity, Efficacy, and Effectiveness of Recombinant Zoster Vaccine for Global Public Health Policy. [PDF]

Vaccines (Basel)
Williams LR, Hombach J, Marti M.
europepmc   +1 more source